| CTRI Number |
CTRI/2022/08/044521 [Registered on: 01/08/2022] Trial Registered Prospectively |
| Last Modified On: |
26/07/2022 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Observational |
|
Type of Study
|
Cross Sectional Study |
| Study Design |
Other |
|
Public Title of Study
|
Comparison of electrical activity of retina between diabetic patients with and without fluid accumulation in the centre of retina |
|
Scientific Title of Study
|
Electroretinogram changes in diabetic patients with and without Diabetic Macular Edema |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Shana K |
| Designation |
Junior resident ophthalmology |
| Affiliation |
Sankara eye hospital, Coimbatore |
| Address |
Sankara eye hospital
Sathy road
Sivanandhapuram
Coimbatore
TamilNadu
Coimbatore TAMIL NADU 641035 India |
| Phone |
7772960052 |
| Fax |
|
| Email |
shanakadakot@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Prabhu Shanker M |
| Designation |
Senior consultant, Retina |
| Affiliation |
Sankara eye hospital, Coimbatore |
| Address |
Sankara eye hospital
Sathy road
Sivanandhapuram
Coimbatore
TamilNadu
Coimbatore TAMIL NADU 641035 India |
| Phone |
9443186568 |
| Fax |
|
| Email |
drprabhushanker@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Prabhu Shanker M |
| Designation |
Senior consultant, Retina |
| Affiliation |
Sankara eye hospital, Coimbatore |
| Address |
Sankara eye hospital
Sathy road
Sivanandhapuram
Coimbatore
TamilNadu
Coimbatore TAMIL NADU 641035 India |
| Phone |
9443186568 |
| Fax |
|
| Email |
drprabhushanker@gmail.com |
|
|
Source of Monetary or Material Support
|
| Sankara eye hospital
Sathy road
Sivanandhapuram
Coimbatore 641035
|
|
|
Primary Sponsor
|
| Name |
Sankara eye hospital Coimbatore |
| Address |
Sankara eye hospital
Sathy road
Sivanandhapuram
Coimbatore
TamilNadu 641035 |
| Type of Sponsor |
Private hospital/clinic |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Shana K |
Sankara eye hospital, Coimbatore |
Sathy road
Sivanandhapuram
Coimbatore, TamilNadu 641035
Department of retina Coimbatore TAMIL NADU |
7772960052
shanakadakot@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional ethics committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: H36||Retinal disorders in diseases classified elsewhere, |
|
|
Intervention / Comparator Agent
|
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
90.00 Year(s) |
| Gender |
Both |
| Details |
1 ) Age above 18 years
2) Patients diagnosed with type I or type II diabetes mellitus
3) Patient with clear media
4) Patients with confirmed DME having NPDR or PDR – cases
5) Patients with DM(diabetes mellitus) , no DR and DME - controls
|
|
| ExclusionCriteria |
| Details |
1 ) Prior history of intravitreal injections
2) Prior history of retinal lasers
3) Significant media opacity
4) Prior history of retinal detachment
5) Prior history of vitrectomy
6) Centre involving diabetic macular edema (that may require
imminent treatment)
7) Ocular abnormality that might impact ERG measurements
(including more than 3 diopters of myopia)
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| ERG patterns in diabetic patients with and without diabetic macular edema |
At baseline |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
Best corrected visual acuity(BCVA) and foveal thickness on spectral domain OCT(SD-OCT)
|
At baseline |
|
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
01/08/2022 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
Not yet |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
•Diabetic macular edema(DME) is the most common cause of vision loss in patients with diabetic retinopathy and is increasing in prevelance globally. •It has been reported that 20% and 14% of subjects with type 1 and 2 diabetes mellitus develop diabetic macular edeme(DME) respectively. •There is impaired function in the middle and inner layers of the retina in diabetic patients before start of vascular complications. Therefore, there is a need for an objective test for early detection and diagnosis of DR and DME •Traditional flash ERG (FERG) devices and multifocal ERG (mfERG) devices are time consuming to use, also these devices require pupil dilatation , the use of invasive corneal electrodes and professional analysis •Recently a portable full-field ERG recording device called the RETeval system was introduced, the advent of which has made it easier to make general judgments about retinal function which has the following advantages: ü It is a small , handled device ü Non invasive : uses special skin electrode to record the ERG patterns ü No need for dilatation of pupil ü Testing time for both eyes is <5mins The DR risk assessment protocol which is provided by the manufacturer was used. A 30-Hz flicker ERG, as set in the electrophysiological standard by the International Society for Clinical Electrophysiology of Vision (ISCEV) , will be used to observe the cone cell response. The study presented herein compares the changes in the flicker electroretinography pattern between diabetic patients with and without diabetic macular edema.
|